Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock Awards Granted (Details)

v3.22.0.1
Schedule of Stock Awards Granted (Details)
 6 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Number of Shares, Outstanding, Beginning balance | shares 604,404
Weighted Average Exercise Price, Outstanding, Beginning balance | $ / shares $ 2.18
Weighted Average Remaining Contractual Term (Years), Outstanding, Beginning balance 4 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding, Beginning balance | $ $ 2,802,420
Number of Shares, Granted | shares 56,659
Weighted Average Exercise Price, Granted | $ / shares $ 6.90
Number of Shares, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Number of Shares, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Number of Shares, Outstanding, Ending balance | shares 661,063
Weighted Average Exercise Price, Outstanding, Ending balance | $ / shares $ 2.59
Weighted Average Remaining Contractual Term (Years), Outstanding, Ending balance 4 years 2 months 12 days
Aggregate Intrinsic Value, Outstanding, Ending balance | $ $ 2,397,469
Number of Shares, Exercisable | shares 81,288
Weighted Average Exercise Price, Exercisable | $ / shares $ 3.08
Weighted Average Remaining Contractual Term (Years), Exercisable 4 years 2 months 12 days
Aggregate Intrinsic Value, Exercisable | $ $ 260,467